NDC 71872-7161-01 - Lidocaine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7161
- Requested NDC
- 71872-7161-01
- Package NDCs from labels
- 71872-7161-1, 71872-7161-01
- Manufacturer
- Medical Purchasing Solutions, LLC
- Effective date
- 2023-05-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine Hydrochloride - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7161-1 | Lidocaine Hydrochloride | 5 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 5 | 2 | |
| 71872-7161-1 | Lidocaine Hydrochloride | 1 in 1 BAG | INJECTION, SOLUTION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7161 | LIDOCAINE HYDROCHLORIDE INJECTION, SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 2 | Current NDC, Legacy NDC, 2 package rows | 20230516_89691444-7bfb-3314-e053-2a95a90a268e.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 3f2c33e5-290e-2f89-e063-6394a90aee69 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42caf92e-6fa9-5bd7-e063-6294a90a3904 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 42d9e4cf-ca73-ec6d-e063-6394a90ae937 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | ProPharma Distribution | 3f2bdb1f-f1c0-370d-e063-6294a90a5c50 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Sodium Chloride | SODIUM CHLORIDE | ProPharma Distribution | 3f79fb8b-d0e8-db2a-e063-6394a90ac136 | 2025-12-18 | Warnings, Adverse reactions | 451W47IQ8X |
| Lidocaine Hydrochloride and Epinephrine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE | ProPharma Distribution | 43048b6b-3c83-eef4-e063-6294a90a34cb | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| lidocaine hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 4643042c-ec95-3bad-e063-6294a90a8250 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| Body Balance | ARALIA QUIN, ARNICA, AVENA, CARDUUS MAR, ELAEIS, GLANDULA SUPRARENALIS SUIS, NAT MUR, PHOSPHORICUM AC, THUJA OCC | Eight and Company L.L.C | 876cc0cf-c7a7-4656-adf9-1eff9bb62687 | 2025-12-18 | Warnings | 451W47IQ8X |
| ZIMS MAX FREEZE | LIDOCAINE HYDROCHLORIDE AND MENTHOL, | KOBAYASHI Healthcare International, Inc. | e364ff83-4aaf-4897-a7da-06581bc321f2 | 2025-12-18 | Warnings | V13007Z41A |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Cardinal Health 107, LLC | 4e46cac7-00cd-4a01-ba11-9af4960cfbe9 | 2025-12-18 | Warnings, Adverse reactions | V13007Z41A |
| ADRENOPLEX | CHELIDONIUM MAJUS, ECHINACEA (ANGUSTIFOLIA), GLANDULA SUPRARENALIS BOVINE, SPLEEN (SUIS), CARDUUS MARIANUS, LYCOPODIUM CLAVATUM, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM | BioActive Nutritional, Inc. | 3c53c23e-7654-4e46-acf1-edb0d605ff3b | 2025-12-18 | Warnings | 451W47IQ8X |
| Vermasode | ARTEMISIA VULGARIS, CHELIDONIUM MAJUS, GRANATUM, SPIGELIA ANTHELMIA, RATANHIA, ARSENICUM ALBUM, FERRUM METALLICUM, CALCAREA CARBONICA, CINA, GAERTNER BACILLUS, GRAPHITES, MERCURIUS DULCIS, NATRUM MURIATICUM, NATRUM PHOSPHORICUM, VERMIN NOSODE | Natural Creations, Inc | 180b5641-5692-42d4-8472-fdadccebd746 | 2025-12-18 | Warnings | 451W47IQ8X |
| ReHydration | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS, KALI PHOS, NAT MUR, SARSAPARILLA, SILICEA, TARAXACUM, THYROIDINUM | Energetix Corporation | 9b532a31-530a-44f9-843f-f395a3e460b8 | 2025-12-17 | Warnings | 451W47IQ8X |
| Equate Yeast Relief | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR | WAL-MART STORES INC | d96aa608-ed8a-36cd-e053-2a95a90ac286 | 2025-12-17 | Warnings | 451W47IQ8X |
| OP-P | EMOTIONAL HEALTH BOOSTER | Vitality Works, Inc. | a8b87a49-fc73-4494-8dc9-059bc5f82d42 | 2025-12-17 | Warnings | 451W47IQ8X |
| Vital-FL | BODY FLUID BALANCE | Vitaltiy Works, Inc. | 13207197-7ef7-49a3-8970-5f98299a75d2 | 2025-12-17 | Warnings | 451W47IQ8X |
| Woman Power | AGNUS, ARALIA QUIN, ARNICA, DAMIANA, LACTUCA, NAT MUR, ONOSMODIUM VIRGINIANUM, OOPHORINUM, PHOSPHORICUM AC, PITUITARUM POSTERIUM, SALIX NIG, SEPIA, THUJA OCC | Eight and Company L.L.C | 614d47de-742b-4944-89c8-59f2f58dc8b9 | 2025-12-17 | Warnings | 451W47IQ8X |
| PSORIASIS HP | ARSENICUM ALBUM, ARSENICUM IODATUM, BORAX, CALCAREA CARBONICA, GRAPHITES, MEZEREUM, PROTEUS, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, SEPIA, SILICEA, SULPHUR, THYROIDINUM | Natural Creations, Inc. | d2522637-fd16-4246-90d8-f90fb224550e | 2025-12-16 | Warnings | 451W47IQ8X |
| Mood | ARALIA QUIN, CIMICIFUGA, SPIGELIA ANTH, ARG NIT, ARSENICUM ALB, AURUM MET, IGNATIA AMARA, LACHESIS, LYCOPODIUM, NAT MUR, PHOSPHORICUM AC, PLATINUM MET, PULSATILLA, SEPIA, THUJA OCC | Natural Creations, Inc | 7f143f30-2b72-4e6c-985c-8d3a485dbdb4 | 2025-12-16 | Warnings | 451W47IQ8X |
| IODIUM HP | BARIUM CARBONATE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, FUCUS VESICULOSUS, IODINE, SODIUM CHLORIDE, PULSATILLA VULGARIS, SPONGIA OFFICINALIS SKELETON, ROASTED, THYROID | Natural Creations, Inc. | 9353d604-e168-4df1-9726-e965c9fc2c78 | 2025-12-16 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.